Adaptimmune Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADAP and other ETFs, options, and stocks.

About ADAP

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8.

CEO

Adrian Rawcliffe

CEOAdrian Rawcliffe

Employees

449

Employees449

Headquarters

Abingdon, Oxfordshire

HeadquartersAbingdon, Oxfordshire

Founded

2014

Founded2014

Employees

449

Employees449

ADAP Key Statistics

Market cap

123.69M

Market cap123.69M

Price-Earnings ratio

-2.23

Price-Earnings ratio-2.23

Dividend yield

—

Dividend yield—

Average volume

1.41M

Average volume1.41M

High today

$0.52

High today$0.52

Low today

$0.475

Low today$0.475

Open price

$0.489

Open price$0.489

Volume

441.20K

Volume441.20K

52 Week high

$2.05

52 Week high$2.05

52 Week low

$0.459

52 Week low$0.459

Analyst ratings

67%

of 9 ratings

Buy

66.7%

Hold

22.2%

Sell

11.1%